Insider Transactions in Q4 2024 at Edgewise Therapeutics, Inc. (EWTX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2024
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
100,000
-87.06%
|
$2,700,000
$27.37 P/Share
|
|
Dec 30
2024
|
Alan J Russell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+46.54%
|
$0
$0.18 P/Share
|
|
Dec 24
2024
|
Marc Semigran Chief Development Officer |
SELL
Open market or private sale
|
Direct |
29,709
-48.64%
|
$861,561
$29.87 P/Share
|
|
Dec 24
2024
|
Marc Semigran Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,709
+44.92%
|
$237,672
$8.94 P/Share
|
|
Oct 11
2024
|
R Michael Carruthers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+47.65%
|
$0
$0.71 P/Share
|